Middle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg.
Sondre HeimarkMaria H MehlumGiuseppe ManciaCamilla L SøraasKnut LiestølKristian WachtellAnne C LarstorpMorten RostrupJulian Eek MariampillaiSverre E KjeldsenStevo JuliusMichael A WeberPublished in: Hypertension (Dallas, Tex. : 1979) (2023)
Our findings may be seen as a signal that caution is warranted when treating middle-aged and older patients with electrocardiographic or echocardiographic LVH to SBP <130 mm Hg.
Keyphrases
- left ventricular
- blood pressure
- fluorescent probe
- left atrial
- hypertrophic cardiomyopathy
- heart failure
- acute myocardial infarction
- cardiac resynchronization therapy
- mitral valve
- aqueous solution
- aortic stenosis
- cardiovascular events
- hypertensive patients
- living cells
- heart rate
- physical activity
- community dwelling
- risk factors
- middle aged
- cardiovascular disease
- adverse drug
- insulin resistance
- adipose tissue
- pulmonary hypertension
- weight loss
- emergency department
- type diabetes
- acute coronary syndrome
- atrial fibrillation
- skeletal muscle
- transcatheter aortic valve replacement